Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan;27(1):134-135.
doi: 10.1016/j.cmi.2020.09.027. Epub 2020 Sep 25.

Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al

Alexis Lacout  1 , Pierre Yves Marcy  2 , Christian Perronne  3
Affiliations
Comment

Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al

Alexis Lacout et al. Clin Microbiol Infect. 2021 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Fiolet T., Guihur A., Rebeaud M., Mulot M., Peiffer-Smadja N., Mahamat-Saleh Y. Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis. Clin Microbiol Infect. 2020 doi: 10.1016/j.cmi.2020.08.022. - DOI - PMC - PubMed
    1. Davido B., Boussaid G., Vaugier I., Lansaman T., Bouchand F., Lawrence C. Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time. Int J Antimicrob Agents. 2020;56 doi: 10.1016/j.ijantimicag.2020.106129. (published online ahead of print, 2020 Aug 2) - DOI - PMC - PubMed
    1. Castelnuovo A., Costanzo S., Antinori A., Berselli N., Blandi L., Bruno R. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: findings from the observational multicentre Italian CORIST study. Eur J Intern Med. 2020 doi: 10.1016/j.ejim.2020.08.019. S0953-6205(20)30335-30336. - DOI - PMC - PubMed
    1. Catteau L., Dauby N., Montourcy M., Bottieau E., Hautekiet J., Goetghebeur E. Low-dose hydroxychloroquine therapy and mortality in hospitalized patients with COVID-19: a nationwide observational study of 8075 participants. Int J Antimicrob Agents. 2020:106144. doi: 10.1016/j.ijantimicag.2020.106144. (published online ahead of print 2020 Aug 24) - DOI - PMC - PubMed
    1. Skipper C.P., Pastick K.A., Engen N.W., Bangdiwala A.S., Abassi M., Lofgren S.M. Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial. Ann Intern Med. 2020 doi: 10.7326/M20-4207. M20-4207 (published online ahead of print, 2020 Jul 16) - DOI - PMC - PubMed